by admin | Nov 19, 2025
The team, led by Professor Honglin Chen, developed the vaccine by utilising a live attenuated influenza virus (LAIV) vaccine platform – DelNS1 LAIV – which they originally developed in 2018. They first used the DelNS1 LAIV platform, which is designed for the...
